Biotech Pulse
Bi-weekly newsletter on biotech breakthroughs — clinical trials, drug approvals, gene therapy, and biomanufacturing.
Key Highlights
- ✓ Bi-weekly delivery (every other Thursday)
- ✓ Clinical trial results summary
- ✓ FDA and EMA approval alerts
- ✓ Gene therapy and CRISPR updates
- ✓ Biomanufacturing innovations
- ✓ 8-minute read format
Overview
A bi-weekly newsletter covering biotech breakthroughs — clinical trial results, drug approvals, gene therapy advances, and biomanufacturing innovations. Delivered every other Thursday.
What's Inside
Newsletter Sections
Each issue: (1) Trial results — key clinical trial readouts, (2) Regulatory watch — FDA/EMA approvals and decisions, (3) Innovation spotlight — a breakthrough technology, (4) Manufacturing update — bioprocessing and supply chain, (5) Funding tracker — biotech venture rounds.
Audience
Written for biotech professionals, investors, and researchers. 20K+ subscribers including pharma executives, VC partners, and academic researchers.
Ready to dive in?
Explore this resource and discover more across our 12 technology frontiers.